
The relation between clinical evidence of and zzso signs of zzso zzso was evaluated by reviewing the clinical and zzso findings in 64 patients studied at zzso all of whom had received zzso or zzso chemotherapy during zzso Of the 64 patients, 20 zzso had documented clinical toxicity consisting of impaired left zzso zzso performance; in 7 zzso of these 20 patients, zzso signs of toxicity were zzso In the remaining 13 patients with clinical zzso zzso signs of toxicity ranged from mild to zzso Of the 44 zzso patients without clinical signs of drug zzso 21 zzso had no zzso sign of zzso in 23 zzso of the patients without clinical zzso however, zzso signs of zzso were nevertheless zzso in most patients, but extensive in zzso Signs of extensive zzso toxicity (19 zzso of 64 zzso were associated with large doses zzso than 450 zzso of the drug, zzso zzso and age greater than 70 zzso This study suggests that attempts to monitor zzso by serial evaluation of cardiac zzso in patients undergoing zzso chemotherapy may be seriously limited by the fact that clinical evidence of toxicity may be present without zzso signs of zzso likewise, zzso signs of zzso toxicity may be present without clinical evidence of zzso 

